Related Experiment Video
Updated: Jan 31, 2026

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Published on: July 19, 2019
[Anticoagulation in patients with cancer]
Sabine Struve1, Jürgen Ringwald2
1Städtisches Klinikum München GmbH, Klinikum Schwabing, Klinik für Hämatologie, Onkologie, Immunologie, Palliativmedizin, Infektiologie und Tropenmedizin.
Cancer patients face higher risks of blood clots (venous thromboembolism) and bleeding. This summary outlines current guidelines for preventing and treating these conditions in cancer care.
Area of Science:
- Oncology
- Hematology
- Clinical Guidelines
Background:
- Cancer patients have a significantly higher risk of venous thromboembolism (VTE) compared to the general population.
- VTE in cancer patients increases morbidity and mortality.
- Anticoagulation for VTE in cancer patients carries a heightened risk of bleeding and recurrence.
Purpose of the Study:
- To summarize current national and international guidelines for VTE prevention and treatment specifically in cancer patients.
- To provide healthcare professionals with a concise overview of evidence-based recommendations.
Main Methods:
- Review and synthesis of existing national and international guidelines.
- Focus on recommendations for prophylaxis, diagnosis, and treatment of VTE in oncology.
Main Results:
- Guidelines emphasize the need for appropriate VTE prophylaxis in cancer patients.
- Early diagnosis and prompt treatment of VTE are crucial.
- Balancing anticoagulation benefits against bleeding risks is a key consideration.
Conclusions:
- Adherence to specific VTE guidelines is mandatory for managing cancer patients.
- These recommendations aim to improve outcomes by addressing the complex risks of VTE and bleeding in this population.
More Related Videos
06:49Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cancer
Patient-centered Care
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Drug Dosing: Geriatric Patients